Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized
about
Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationIdentification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejectionInterleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosisGraft failure in the modern era of allogeneic hematopoietic SCT.Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen.Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment.Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacementNatural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo.Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance.Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.The pentostatin plus cyclophosphamide nonmyeloablative regimen induces durable host T cell functional deficits and prevents murine marrow allograft rejection.Discovery and development of small molecule SHIP phosphatase modulators.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Epidermal keratinocyte-derived basophil promoting activity. Role of interleukin 3 and soluble CD23.Survival and function of MiHA epitope-specific host CD8 TM cells following ablative conditioning and HCTHost factors that impact the biodistribution and persistence of multipotent adult progenitor cells.Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skinIn vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allograftsDonor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humansTransgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.Graft failure after allogeneic hematopoietic cell transplantationContrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cellsGranulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.Role of regulatory T cells in transferable immunological tolerance to bone marrow donor in murine mixed chimerism model.Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.Mouse models in bone marrow transplantation and adoptive cellular therapy.The innate immune system in transplantation.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors.Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye).IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses.A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.
P2860
Q26767440-C3CB1D73-A4F9-4E06-A97E-9FF341759575Q28570224-F2730A2A-9C0F-4DEF-B027-904249873111Q28591879-5AA0D594-36C7-47FE-A2E4-65AA51F1E3DBQ33404733-41895B09-D829-4E50-83C1-CC0FBE930577Q33499668-6722617F-08A5-4087-8EE9-8560E25E04B6Q33556957-88FE170C-C386-40BA-8FDF-3F201837C96AQ34021167-FEA9BE71-8187-4F49-9B4E-42B0C065A763Q34087767-4926B0DC-095C-4030-AC0D-74CA3F9407E9Q34231351-2201571E-00CC-4E89-B5F2-F1F5397A9277Q34313946-9CCDED94-C9B0-400A-9BE3-AC93FB72743BQ34700443-4863A779-2B9A-44BC-BEEB-20FBE7A9DEC9Q35058356-F48D3017-2F13-4B6A-A0DE-31A13A2EE4FBQ35209364-FE0B3C80-41A7-41D1-AB33-C2C9A483FDE5Q35606347-20A3E32C-461A-451D-B9B8-03BBC1B4EB75Q35792738-8535FE68-AD65-4346-9E0F-502F93132C23Q35848288-D9B5303E-B113-46E7-B852-191A0AA2D8A3Q35925091-8310404F-B2C8-404E-935C-0C5E6686900BQ36345757-ACC4C94B-FD85-4785-988C-CF1654D7D629Q36350708-42BA9A24-FE10-47D4-A1FD-F44054DDBA3AQ36351978-E75270F4-4A2F-4C39-9352-C189BBAD3933Q36362155-0D4237FE-BE6F-4CD8-84EA-2E5A84E9E2C1Q36367509-B6040CCE-EC86-4500-8750-C005EE3CD430Q36466103-5B2E8CBE-98BC-432F-B923-FEE290995B4EQ36706319-83F36DE8-975C-45B9-B7D6-F9F369FFB086Q36902123-1CE6317B-AF69-4E14-9E13-04D7E15E3435Q37045988-C0BC67A3-14A1-45F8-B212-3404195B94A6Q37070759-33CF21AF-9F2E-479B-98D4-7EC945916BE6Q37095317-625ECA00-EE3A-49B8-8576-C1D8E5C41D26Q37256962-5B17B8EF-9FFE-4B53-ADC1-09A7758646E5Q37369087-1A6F286D-5378-4232-80C9-AF9C09F6BACCQ37378735-10B53D44-8CFB-4D52-B202-0E1F0FA4DB2CQ37445265-9770BF71-FB77-4F67-A07B-32A1CE8EE523Q37677563-CE34CD53-F2DC-4D1F-80CB-6A37AC007D07Q37896918-E2B8A16B-9EF6-4342-84CF-4D1B16BD1E2EQ38151057-6A3BF8CE-8622-49B6-AFB2-BA29134325DBQ38460376-B75CDF3E-9516-4D43-AB8F-345B2B81CF8DQ41373630-735333C8-1C45-442E-96C9-D02881D2D1C0Q41874469-F41BA0CE-81CF-4ABC-884B-C567CD7962E0Q42418917-9452FB49-C23C-45E9-8AE0-B9AB72E36322Q42948003-96163D2B-7082-4DF9-A2D5-B97E7E3F4D80
P2860
Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Acute rejection of murine bone ...... and target antigens recognized
@ast
Acute rejection of murine bone ...... and target antigens recognized
@en
type
label
Acute rejection of murine bone ...... and target antigens recognized
@ast
Acute rejection of murine bone ...... and target antigens recognized
@en
prefLabel
Acute rejection of murine bone ...... and target antigens recognized
@ast
Acute rejection of murine bone ...... and target antigens recognized
@en
P2093
P2860
P356
P1476
Acute rejection of murine bone ...... and target antigens recognized
@en
P2093
P2860
P304
P356
10.1084/JEM.166.5.1499
P407
P577
1987-11-01T00:00:00Z